About this trial
The goal of this observational study is to determine whether macrophage/monocyte mediated inflammatory signaling contributes to reduced anesthetic requirements in older adults undergoing major abdominal surgery. The main questions it aims to answer are:
* Is there a difference in anesthetic dosing requirements (minimum effective dose) between young and older patients undergoing major abdominal surgery? * How do electroencephalographic (EEG) signatures under anesthesia correlate with age and systemic inflammatory markers? * Is there an association between age, levels of circulating inflammatory cytokines, and monocyte/macrophage phenotypes with anesthetic requirements?
If there is a comparison group: Researchers will compare older adult patients undergoing major abdominal surgery to younger adult patients undergoing major abdominal surgery to see if macrophage/monocyte-mediated inflammatory signaling influences anesthetic sensitivity and the risk of postoperative neurocognitive complications in the older population.
Participants will:
* Receive general anesthesia for major abdominal surgery, with continuous recording of anesthetic dose requirements. * Undergo electroencephalographic (EEG) monitoring during the anesthetic period. * Provide blood samples for the measurement of circulating inflammatory cytokines and the assessment of monocyte phenotypes. * Provide peritoneal tissue samples (collected during surgery) to evaluate tissue macrophage populations. * Provide cerebrospinal fluid (CSF) samples to assess biomarkers of blood-brain barrier permeability.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18-30 years or over 60 years old
Scheduled for abdominal surgery
General anesthesia planned with or without spinal anesthesia
Able and willing to provide written informed consent.
Disqualifiers
Chemotherapy or systemic corticosteroid use within the past 2 weeks.
Pregnancy.
Active sepsis or systemic infection.
Emergency surgery.
Trial population
Adult patients from Hospital Clínico Universidad de Chile, in Santiago de Chile, that require elective abdominal surgery and are willing to participate in the study, meeting inclusion criteria and signing the informed consent.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Frontal EEG alpha-band power
Relative EEG alpha power during surgery under general anesthesia guided by standard age-adjusted dosing
Secondary outcomes
Time-to-loss of consciousness
During propofol slow induction, the time required for unresponsiveness to verbal stimuli
Intraoperative anesthetic requirements
Total dose and infusion rate of propofol and/or sevoflurane adjusted using frontal EEG monitoring
Time to emergence
Time in minutes to eye opening since end of anesthesia, with verbal stimuli.
Cytokine circulating profile
Serum inflammatory cytokine profile
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: